Advances in lipids design for LNP-mediated DNA and RNA delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Non-viral gene delivery systems like lipid nanoparticles (LNPs) are crucial for targeted genetic material delivery.
• LNPs offer advantages over traditional carriers, including high biosafety, reproducibility, and efficient nucleic acid delivery.

Purpose of the Study:

• To review recent advancements in LNP-based delivery platforms.
• To analyze structure-activity relationships and delivery mechanisms of LNPs.
• To discuss challenges and future directions for clinical translation of LNP technology.

Main Methods:

• Literature review focusing on LNP structure-activity relationships and delivery mechanisms.
• Analysis of preclinical and clinical data on LNP applications.
• Examination of strategies to overcome LNP limitations.

Main Results:

• LNPs demonstrate high biosafety, reproducibility, and efficient delivery of DNA, mRNA, and siRNA.
• Key challenges include targeting specificity, biocompatibility, manufacturing, and regulatory issues.
• Pioneering strategies like SORT nanoparticles and biodegradable lipids enhance LNP performance.

Conclusions:

• LNPs hold significant promise for gene therapy, particularly in oncology and regenerative medicine.
• Further research is needed to address clinical translation challenges.
• Optimizing LNP design is essential for next-generation nucleic acid delivery systems.